vs

Side-by-side financial comparison of Fabrinet (FN) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Fabrinet is the larger business by last-quarter revenue ($1.1B vs $665.5M, roughly 1.7× Natera, Inc.). Fabrinet runs the higher net margin — 9.9% vs 7.1%, a 2.8% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 35.9%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-5.3M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 24.4%).

Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

FN vs NTRA — Head-to-Head

Bigger by revenue
FN
FN
1.7× larger
FN
$1.1B
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+3.9% gap
NTRA
39.8%
35.9%
FN
Higher net margin
FN
FN
2.8% more per $
FN
9.9%
7.1%
NTRA
More free cash flow
NTRA
NTRA
$43.2M more FCF
NTRA
$37.8M
$-5.3M
FN
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
24.4%
FN

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FN
FN
NTRA
NTRA
Revenue
$1.1B
$665.5M
Net Profit
$112.6M
$47.3M
Gross Margin
12.2%
Operating Margin
10.1%
-3.4%
Net Margin
9.9%
7.1%
Revenue YoY
35.9%
39.8%
Net Profit YoY
30.0%
187.9%
EPS (diluted)
$3.11
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FN
FN
NTRA
NTRA
Q4 25
$1.1B
$665.5M
Q3 25
$978.1M
$592.2M
Q2 25
$909.7M
$546.6M
Q1 25
$871.8M
$501.8M
Q4 24
$833.6M
$476.1M
Q3 24
$804.2M
$439.8M
Q2 24
$753.3M
$413.4M
Q1 24
$731.5M
$367.7M
Net Profit
FN
FN
NTRA
NTRA
Q4 25
$112.6M
$47.3M
Q3 25
$95.9M
$-87.5M
Q2 25
$87.2M
$-100.9M
Q1 25
$81.3M
$-66.9M
Q4 24
$86.6M
$-53.8M
Q3 24
$77.4M
$-31.6M
Q2 24
$81.1M
$-37.5M
Q1 24
$80.9M
$-67.6M
Gross Margin
FN
FN
NTRA
NTRA
Q4 25
12.2%
Q3 25
11.9%
Q2 25
12.2%
Q1 25
11.7%
Q4 24
12.1%
Q3 24
12.3%
Q2 24
12.3%
Q1 24
12.4%
Operating Margin
FN
FN
NTRA
NTRA
Q4 25
10.1%
-3.4%
Q3 25
9.6%
-16.5%
Q2 25
9.8%
-20.2%
Q1 25
9.0%
-15.8%
Q4 24
9.5%
-13.6%
Q3 24
9.6%
-8.9%
Q2 24
9.7%
-10.6%
Q1 24
9.7%
-20.2%
Net Margin
FN
FN
NTRA
NTRA
Q4 25
9.9%
7.1%
Q3 25
9.8%
-14.8%
Q2 25
9.6%
-18.5%
Q1 25
9.3%
-13.3%
Q4 24
10.4%
-11.3%
Q3 24
9.6%
-7.2%
Q2 24
10.8%
-9.1%
Q1 24
11.1%
-18.4%
EPS (diluted)
FN
FN
NTRA
NTRA
Q4 25
$3.11
$0.36
Q3 25
$2.66
$-0.64
Q2 25
$2.41
$-0.74
Q1 25
$2.25
$-0.50
Q4 24
$2.38
$-0.41
Q3 24
$2.13
$-0.26
Q2 24
$2.22
$-0.30
Q1 24
$2.21
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FN
FN
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$960.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.2B
$1.7B
Total Assets
$3.3B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FN
FN
NTRA
NTRA
Q4 25
$960.8M
Q3 25
$968.8M
$1.0M
Q2 25
$934.2M
$16.0M
Q1 25
$950.7M
$17.8M
Q4 24
$934.6M
$22.7M
Q3 24
$908.9M
$29.5M
Q2 24
$858.6M
$90.3M
Q1 24
$794.0M
$69.1M
Stockholders' Equity
FN
FN
NTRA
NTRA
Q4 25
$2.2B
$1.7B
Q3 25
$2.1B
$1.3B
Q2 25
$2.0B
$1.2B
Q1 25
$1.9B
$1.2B
Q4 24
$1.8B
$1.2B
Q3 24
$1.8B
$878.5M
Q2 24
$1.7B
$836.5M
Q1 24
$1.7B
$794.1M
Total Assets
FN
FN
NTRA
NTRA
Q4 25
$3.3B
$2.4B
Q3 25
$3.0B
$1.8B
Q2 25
$2.8B
$1.8B
Q1 25
$2.6B
$1.7B
Q4 24
$2.5B
$1.7B
Q3 24
$2.4B
$1.6B
Q2 24
$2.3B
$1.5B
Q1 24
$2.2B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FN
FN
NTRA
NTRA
Operating Cash FlowLast quarter
$46.3M
$73.9M
Free Cash FlowOCF − Capex
$-5.3M
$37.8M
FCF MarginFCF / Revenue
-0.5%
5.7%
Capex IntensityCapex / Revenue
4.6%
5.4%
Cash ConversionOCF / Net Profit
0.41×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$102.3M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FN
FN
NTRA
NTRA
Q4 25
$46.3M
$73.9M
Q3 25
$102.6M
$59.4M
Q2 25
$55.1M
$37.6M
Q1 25
$74.2M
$44.5M
Q4 24
$115.9M
$52.9M
Q3 24
$83.2M
$51.8M
Q2 24
$83.1M
$4.0M
Q1 24
$100.9M
$27.0M
Free Cash Flow
FN
FN
NTRA
NTRA
Q4 25
$-5.3M
$37.8M
Q3 25
$57.3M
$37.0M
Q2 25
$4.7M
$11.7M
Q1 25
$45.7M
$22.6M
Q4 24
$94.0M
$34.8M
Q3 24
$62.9M
$35.5M
Q2 24
$70.4M
$-7.7M
Q1 24
$87.3M
$6.7M
FCF Margin
FN
FN
NTRA
NTRA
Q4 25
-0.5%
5.7%
Q3 25
5.9%
6.2%
Q2 25
0.5%
2.1%
Q1 25
5.2%
4.5%
Q4 24
11.3%
7.3%
Q3 24
7.8%
8.1%
Q2 24
9.3%
-1.9%
Q1 24
11.9%
1.8%
Capex Intensity
FN
FN
NTRA
NTRA
Q4 25
4.6%
5.4%
Q3 25
4.6%
3.8%
Q2 25
5.5%
4.7%
Q1 25
3.3%
4.3%
Q4 24
2.6%
3.8%
Q3 24
2.5%
3.7%
Q2 24
1.7%
2.8%
Q1 24
1.9%
5.5%
Cash Conversion
FN
FN
NTRA
NTRA
Q4 25
0.41×
1.56×
Q3 25
1.07×
Q2 25
0.63×
Q1 25
0.91×
Q4 24
1.34×
Q3 24
1.07×
Q2 24
1.02×
Q1 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FN
FN

Optical Communications$832.6M73%
Non Optical Communications$300.3M27%

NTRA
NTRA

Segment breakdown not available.

Related Comparisons